CORNEALPREV: Corneal Lesions in Intensive Care Unit (ICU) Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center

Sponsor
Hospital Risoleta Tolentino Neves (Other)
Overall Status
Completed
CT.gov ID
NCT02293876
Collaborator
Conselho Nacional de Desenvolvimento Científico e Tecnológico (Other), Fundação de Amparo à Pesquisa do estado de Minas Gerais (Other)
360
1
4
19
18.9

Study Details

Study Description

Brief Summary

The purpose of the study is find out the better measure to achieve corneal protection in an Intensive Care Unit.

Condition or Disease Intervention/Treatment Phase
  • Device: LACRIBELL®
  • Device: LIPOSIC®
  • Device: Glad wrap
N/A

Detailed Description

Critically ill patients are at higher risk for corneal injury and the mechanisms responsible for ocular lubrication and protection can be compromised. However, the literature diverges on which is the best clinical practice for treatment. There is a scale for assessing the risk for corneal injury. Thus, the general objective of this study was to evaluate the risk for developing corneal injury in critically ill patients and the effectiveness of three types of interventions: eye gel, eyedrops and polyethylene film, compared to the control group in its prevention. The specific objectives were: verify the most effective intervention for the prevention of corneal injury from the available literature and provided by: eye gel, eyedrops and polyethylene film compared to the control group who received eye care through randomized controlled clinical trial. Patients and methods: This study was a randomized controlled trial to determine the best care for the prevention of corneal injury from those available on the market (eye drops, eye gel and polyethylene film), compared to a control group (eye care) in the period from 09/07/2013 to 03/15/2014 .

Study Design

Study Type:
Interventional
Actual Enrollment :
360 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Investigator)
Primary Purpose:
Prevention
Official Title:
Risk for Corneal Injury in Critically Ill Patients and Effect of Nursing Interventions for Its Prevention: Randomized Controlled Trial
Study Start Date :
Apr 1, 2013
Actual Primary Completion Date :
Apr 1, 2014
Actual Study Completion Date :
Nov 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: Eye drop

Eye drop LACRIBELL® - two drops each eye, three times a day, after eye cleansing.

Device: LACRIBELL®
Hypromellose and dextran based eyedrop, used in the treatment of dry eye.
Other Names:
  • Eyedrop
  • Sham Comparator: Ocular gel

    Ocular gel LIPOSIC® applied three times a day at the lower palpebra from medium line to the lateral border.

    Device: LIPOSIC®
    Carbomer and Sorbitol based gel, used in the treatment of dry eye.
    Other Names:
  • Occular Gel
  • Sham Comparator: Glad wrap

    Occlusion of the orbital area with a Glad wrap, turning the area into a moisture chamber.

    Device: Glad wrap
    A clear plastic wrap occluding eye and orbital area, turning the space into a moisture chamber.
    Other Names:
  • Polyethylene film
  • No Intervention: Control group

    Ocular cleansing three times a day.

    Outcome Measures

    Primary Outcome Measures

    1. Keratitis [Five days]

      Presence of keratitis visible with a cobalt light ophthalmoscope and fluorescein eye drop.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 93 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Ramsay sedation scale 5 or 6

    • Glasgow coma scale lower than 7

    • Use of oxygen therapy by facial device above 6 liters per minute or mechanical ventilation

    • Blink reflex less than 5 times per minute or ocular globe exposure

    Exclusion Criteria:
    • Less than 48 hours in Intensive Care Unit

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Risoleta Tolentino Neves Belo Horizonte Minas Gerais Brazil 31744012

    Sponsors and Collaborators

    • Hospital Risoleta Tolentino Neves
    • Conselho Nacional de Desenvolvimento Científico e Tecnológico
    • Fundação de Amparo à Pesquisa do estado de Minas Gerais

    Investigators

    • Principal Investigator: Andreza Werli-Alvarenga, RN, MD, PhD, Hospital Risoleta Tolentino Neves

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Andreza Werli Alvarenga, RN, MD, PhD, Hospital Risoleta Tolentino Neves
    ClinicalTrials.gov Identifier:
    NCT02293876
    Other Study ID Numbers:
    • ICU CORNEAL ULCER 01
    First Posted:
    Nov 18, 2014
    Last Update Posted:
    Nov 19, 2014
    Last Verified:
    Nov 1, 2014
    Keywords provided by Andreza Werli Alvarenga, RN, MD, PhD, Hospital Risoleta Tolentino Neves
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 19, 2014